By Natalie Grover and Danilo Masoni LONDON (Reuters) – Shares of GSK and Sanofi surged on Wednesday, adding more than…
Analysis-EU avoids sledgehammer to crack euro clearing nut – for now
By Huw Jones LONDON (Reuters) – European Union plans to shift derivatives clearing worth trillions of euros from London to…
Explainer-Europe set to import banned Russian diesel without knowing
By Rowena Edwards LONDON (Reuters) – European motorists could find Russian diesel in their tanks even after bans take effect…
Marketmind: Crude deflation?
A look at the day ahead in U.S. and global markets from Mike Dolan. With everyone on Wall St seemingly…
European tech industry loses $400 billion market value, report says
By Martin Coulter and Supantha Mukherjee LONDON/STOCKHOLM (Reuters) – The European tech industry saw $400 billion in value wiped out…
Marketmind: Hat-trick
A look at the day ahead in European and global markets from Anshuman Daga While European shares ended lower for…
Inflation miss puts central bankers on back foot
By Howard Schneider, Balazs Koranyi and Mark John WASHINGTON (Reuters) – Thomas Barkin, Richmond Federal Reserve President, was poring over…
Dollar to rebound, accumulate safe-haven strength in 2023: Reuters poll
By Indradip Ghosh BENGALURU (Reuters) – The dollar will rebound against most currencies over the coming months, with the growing…
U.S. watchdog levies $7.7 million in fines against KPMG entities
By Chris Prentice (Reuters) -A U.S. agency tasked with overseeing the audits of public companies on Tuesday said it imposed…
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
By Brendan Pierson (Reuters) – Drugmakers GSK Plc, Pfizer Inc, Sanofi SA and Boehringer Ingelheim on Tuesday were spared thousands…